Constitutive/hypoxic degradation of HIF-α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein

被引:62
|
作者
Kong, Xianguo
Alvarez-Castelao, Beatriz
Lin, Zhao
Castano, Jose G.
Caro, Jaime
机构
[1] Thomas Jefferson Univ, Cardeza Fdn, Philadelphia, PA 19107 USA
[2] UAM, Fac Med, CSIC, Dept Bioquim, Madrid, Spain
[3] UAM, Inst Invest Biomed Alberto Sols, CSIC, Fac Med, Madrid, Spain
关键词
D O I
10.1074/jbc.M700704200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional activator complex HIF-1 plays a key role in the long term adaptation of cells and tissues to their hypoxic microenvironment by stimulating the expression of genes involved in angiogenesis and glycolysis. The expression of the HIF-1 complex is regulated by the levels of its HIF-alpha subunits that are degraded under normoxic conditions by the ubiquitin-proteasome system. Whereas this pathway of HIF-alpha protein degradation has been well characterized, little is known of their turnover during prolonged hypoxic conditions. Herein, we describe a pathway by which HIF-1 alpha and HIF-2 alpha proteins are constitutively degraded during hypoxia by the proteasome system, although without requirement of prior ubiquitylation. The constitutive/hypoxic degradation of HIF-alpha proteins is independent of the presence of VHL, binding to DNA, or the formation of a transcriptionally active HIF-1 complex. These results are further strengthened by the demonstration that HIF-alpha proteins are directly degraded in a reconstituted in vitro assay by the proteasome. Finally, we demonstrate that the persistent down-regulation of HIF-1 alpha during prolonged hypoxia is mainly caused by a decreased production of the protein without change in its degradation rate. This constitutive, ubiquitin-independent proteasomal degradation pathway of HIF-alpha proteins has to be taken into account in understanding the biology as well as in the development of therapeutic interventions of highly hypoxic tumors.
引用
收藏
页码:15498 / 15505
页数:8
相关论文
共 50 条
  • [31] Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP
    Sang, NL
    Fang, J
    Srinivas, V
    Leshchinsky, I
    Caro, J
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (09) : 2984 - 2992
  • [32] Calpain mediates a von Hippel-Lindau protein-independent destruction of hypoxia-inducible factor-1α
    Zhou, J
    Köhl, R
    Herr, B
    Frank, R
    Brüne, B
    MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (04) : 1549 - 1558
  • [33] SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel-Lindau protein ubiquitination and degradation
    Yin, Rusha
    Liu, Shuai
    CANCER SCIENCE, 2021, 112 (10) : 4100 - 4111
  • [34] Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel–Lindau protein
    Paul G Corn
    E Robert McDonald
    James G Herman
    Wafik S El-Deiry
    Nature Genetics, 2003, 35 : 229 - 237
  • [35] Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions
    Jung, Youn-Sang
    Lee, Su-Jin
    Yoon, Min-Ho
    Ha, Nam Chul
    Park, Bum-Joon
    CELL CYCLE, 2012, 11 (23) : 4462 - 4473
  • [36] Von Hippel-Lindau (VHL) Protein Antagonist VH298 Improves Wound Healing in Streptozotocin-Induced Hyperglycaemic Rats by Activating Hypoxia-Inducible Factor- (HIF-) 1 Signalling
    Qiu, Shuo
    Jia, Yachao
    Sun, Yunchu
    Han, Pei
    Xu, Jia
    Wen, Gen
    Chai, Yimin
    JOURNAL OF DIABETES RESEARCH, 2019, 2019
  • [37] Clusterin is a secreted marker for a hypoxia-inducible factor- independent function of the von Hippel-Lindau tumor suppressor protein
    Nakamura, E
    Abreu-e-Lima, P
    Awakura, Y
    Inoue, T
    Kamoto, T
    Ogawo, O
    Kotani, H
    Manabe, T
    Zhang, GJ
    Kondo, K
    Nosé, V
    Kaelin, WG
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (02): : 574 - 584
  • [38] Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1α mediated transcription
    Ampofo, Emmanuel
    Kietzmann, Thomas
    Zimmer, Andreas
    Jakupovic, Mirza
    Montenarh, Mathias
    Goetz, Claudia
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (10): : 1729 - 1735
  • [39] Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein
    Corn, PG
    McDonald, ER
    Herman, JG
    El-Deiry, WS
    NATURE GENETICS, 2003, 35 (03) : 229 - 237
  • [40] Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors
    Schnell, PO
    Ignacak, ML
    Bauer, AL
    Striet, JB
    Paulding, WR
    Czyzyk-Krzeska, MF
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 (02) : 483 - 491